All enrolled clients who acquired no less than just one dose of zosuquidar or placebo during induction were being monitored with the incidence of adverse activities (439 individuals, 219 on zosuquidar and 210 on placebo). The commonest adverse situations ended up connected with the period of extended and considerable myelosuppression https://jamesd443sdo6.shoutmyblog.com/profile